Per the federal government’s Congressional Budget Office, there will be “negligible effect” on allowing the government to negotiate drug prices for the Medicare Part D program. Although the government negotiates for the Department of Veterans Affairs, the list of drugs on their formulary list is limited and would restrict Medicare beneficiaries’ choices on treatment. Read article here….
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.